160 related articles for article (PubMed ID: 22333263)
1. Fatal acute pulmonary injury associated with everolimus.
Depuydt P; Nollet J; Benoit D; Praet M; Caes F
Ann Pharmacother; 2012 Mar; 46(3):e7. PubMed ID: 22333263
[TBL] [Abstract][Full Text] [Related]
2. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
3. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
[TBL] [Abstract][Full Text] [Related]
4. Everolimus-associated pneumonitis in 3 heart transplant recipients.
Otton J; Hayward CS; Keogh AM; Glanville AR; Macdonald PS
J Heart Lung Transplant; 2009 Jan; 28(1):104-6. PubMed ID: 19134540
[TBL] [Abstract][Full Text] [Related]
5. Diffuse alveolar hemorrhage induced by everolimus.
Vandewiele B; Vandecasteele SJ; Vanwalleghem L; De Vriese AS
Chest; 2010 Feb; 137(2):456-9. PubMed ID: 20133293
[TBL] [Abstract][Full Text] [Related]
6. Early everolimus-induced pneumonitis in a renal transplant recipient: A case report.
Sułkowska K; Palczewski P; Miszewska-Szyszkowska D; Durlik M; Gołębiowski M; Małkowski P
Ann Transplant; 2012 Dec; 17(4):144-8. PubMed ID: 23274336
[TBL] [Abstract][Full Text] [Related]
7. Everolimus-induced severe pulmonary toxicity with diffuse alveolar hemorrhage.
Junpaparp P; Sharma B; Samiappan A; Rhee JH; Young KR
Ann Am Thorac Soc; 2013 Dec; 10(6):727-9. PubMed ID: 24364783
[No Abstract] [Full Text] [Related]
8. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
9. Life-Threatening Everolimus-Associated Pneumonitis: A Case Report and a Review of the Literature.
Almeida F; Amorim S; Sarmento A; Santos L
Transplant Proc; 2018 Apr; 50(3):933-938. PubMed ID: 29588066
[TBL] [Abstract][Full Text] [Related]
10. A case of everolimus-associated chylothorax in a cardiac transplant recipient.
Fukushima N; Saito S; Sakata Y; Sawa Y
Transplant Proc; 2013 Oct; 45(8):3144-6. PubMed ID: 24157052
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
Lehmkuhl H; Hetzer R
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S201-5; discussion S210-1. PubMed ID: 15774323
[TBL] [Abstract][Full Text] [Related]
12. Everolimus: a guide to its use in liver transplantation.
Keating GM; Lyseng-Williamson KA
BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253
[TBL] [Abstract][Full Text] [Related]
13. Fatal case of cryptogenic organizing pneumonia associated with everolimus.
Nazer L; Alnajjar T; Salah S; Khzouz J; Alfaqeer N; Qandeel M
Ann Saudi Med; 2014; 34(5):437-9. PubMed ID: 25827702
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS
Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
Garrean S; Massad MG; Tshibaka M; Hanhan Z; Caines AE; Benedetti E
Clin Transplant; 2005 Oct; 19(5):698-703. PubMed ID: 16146565
[TBL] [Abstract][Full Text] [Related]
17. Everolimus in clinical practice in long-term liver transplantation: an observational study.
Casanovas T; Argudo A; Peña-Cala MC
Transplant Proc; 2011; 43(6):2216-9. PubMed ID: 21839237
[TBL] [Abstract][Full Text] [Related]
18. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus.
Cetin B; Coskun U; Yildiz R; Buyukberber S; Baykara M; Benekli M
J Oncol Pharm Pract; 2011 Sep; 17(3):274-8. PubMed ID: 20215482
[TBL] [Abstract][Full Text] [Related]
19. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
Cibrik D; Silva HT; Vathsala A; Lackova E; Cornu-Artis C; Walker RG; Wang Z; Zibari GB; Shihab F; Kim YS
Transplantation; 2013 Apr; 95(7):933-42. PubMed ID: 23422495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
